Holen Sie sich die Stockscreener-App
1.852
4.63%
0.082
Schlusskurs vom Vortag:
$1.77
Offen:
$1.76
24-Stunden-Volumen:
24,897
Relative Volume:
0.21
Marktkapitalisierung:
$4.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+12.93%
1M Leistung:
-6.95%
6M Leistung:
-83.90%
1J Leistung:
-96.75%
1-Tages-Spanne:
$1.755
$1.8799
1-Wochen-Bereich:
$1.60
$1.8799
52-Wochen-Spanne:
$1.52
$75.80
Autonomix Medical Inc Stock (AMIX) Company Profile
Firmenname
Autonomix Medical Inc
Sektor
Branche
Telefon
832-277-7816
Adresse
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Vergleichen Sie AMIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
1.852 | 4.02M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix Medical announces inducement grant - Medical Buyer
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Autonomix Medical Expands Team with Strategic 5,000-Share Stock Option Grant to New Key Employee - Stock Titan
Autonomix Medical Granted European Patent For Catheter-Based Neuromodulation Technology - Nasdaq
Autonomix Medical Gains European Patent for Catheter-Based Tech - Medical Product Outsourcing
Autonomix Medical secures new European patent for nerve tech - Investing.com
Autonomix Medical Granted New European Patent For Proprietary Catheter-Based Technology - marketscreener.com
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology - GlobeNewswire
Autonomix Medical secures new European patent for nerve tech By Investing.com - Investing.com Canada
Medical Breakthrough: Autonomix's New EU Patent Powers Multi-Condition Treatment Platform - Stock Titan
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline - Investing.com Australia
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline By Investing.com - Investing.com South Africa
Analyzing Globus Medical (NYSE:GMED) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix to begin U.S. clinical studies for FDA approval By Investing.com - Investing.com South Africa
Autonomix to begin U.S. clinical studies for FDA approval - Investing.com
Autonomix Medical, Inc. Engages Leading Medical Experts to - GlobeNewswire
Top Medical Experts Join Forces to Advance Revolutionary Pancreatic Cancer Pain Treatment - Stock Titan
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) - GlobeNewswire
Revolutionary Pancreatic Cancer Pain Treatment: Autonomix Medical Reveals First Clinical Results at ECIO 2025 - Stock Titan
Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update - Defense World
Patent Granted to Autonomix Medical for Sensing Data Collection - Medical Product Outsourcing
Autonomix stock plunges to 52-week low of $1.81 amid market challenges By Investing.com - Investing.com South Africa
Autonomix stock plunges to 52-week low of $1.81 amid market challenges - Investing.com Australia
Financial Analysis: INVO Bioscience (NASDAQ:INVO) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix Medical announces inducement grant under Nasdaq listing rule 5635(C)(4) - Marketscreener.com
Autonomix Medical Awards Strategic Stock Options Package Under Nasdaq Rules - StockTitan
Can Autonomix Sensing And RF Ablation System Prove Its Mettle In Managing Pancreatic Cancer Pain? - RTTNews
Autonomix Medical Granted US Patent for Catheter-Based Technology; Shares Up 10% Pre-Bell - Marketscreener.com
Autonomix Medical Expands Patent Portfolio with New Issuance for Innovative Sensing and Ablation Technology - Nasdaq
Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology - The Manila Times
Autonomix Medical, Inc. Granted U.S. Patent Covering - GlobeNewswire
Groundbreaking Patent: Autonomix Medical's New Tech 3000x More Sensitive Than Current Solutions - StockTitan
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) versus SI-BONE (NASDAQ:SIBN) - Defense World
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest - Defense World
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix advances pancreatic cancer treatment system - Investing.com Australia
Autonomix Medical Advances Toward US Clinical Trials In 2025 With Apex 6 Generator Integration - Nasdaq
Autonomix advances toward U.S. clinical trials in 2025 - TipRanks
Autonomix advances pancreatic cancer treatment system By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation - The Manila Times
Autonomix Medical Achieves Design Lock for Apex 6 Radiofrequency Generator, Advances Towards U.S. Clinical Trials for Pancreatic Cancer Pain Treatment - Nasdaq
Autonomix Medical, Inc. Advances Toward U.S. Clinical - GlobeNewswire
Autonomix Achieves Critical Milestone: FDA-Cleared Technology Powers New Cancer Pain Treatment System - StockTitan
Autonomix stock plunges to 52-week low of $2.23 amid market challenges - Investing.com Australia
Autonomix stock plunges to 52-week low of $2.23 amid market challenges By Investing.com - Investing.com South Africa
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Autonomix Medical, Inc. Announces Abstract Highlighting Technology And Early Proof-Of-Concept Study Results Accepted At The Society Of Interventional Radiology (SIR) Annual Scientific Meeting - MENAFN.COM
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - GlobeNewswire
Can This New Technology Transform Pancreatic Cancer Pain Management? Major Conference Takes Notice - StockTitan
Autonomix stock hits 52-week low at $2.54 amid steep annual decline - Investing.com
Finanzdaten der Autonomix Medical Inc-Aktie (AMIX)
Es liegen keine Finanzdaten für Autonomix Medical Inc (AMIX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.01%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):